Articles from McKesson Ventures

Top healthcare investors and entrepreneurs weigh in on priorities, challenges and the direction of innovation across the pharmaceutical value chain

McKesson Ventures’ managing director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance, and who are recognized as leaders by portfolio company CEOs, industry peers and colleagues.